Table 3.
Univariate analysis of factors associated with overall survival of 163 patients with HCC
| OS | |||
|---|---|---|---|
| univariate analysis | |||
| HR | 95%CI | p-value | |
| Age(>50vs.≤50) | 1.15 | 0.77-1.37 | 0.47 |
| Gender (male vs. female) | 1.61 | 0.92-2.81 | 0.10 |
| AFP (≤20 vs.>20) | 0.77 | 0.52-1.14 | 0.19 |
| HBV (positive vs. negative) | 1.03 | 0.59-1.78 | 0.93 |
| HCV (positive vs. negative) | 0.69 | 0.22-2.19 | 0.53 |
| Cirrhosis (yes vs. no) | 1.34 | 0.90-1.99 | 0.15 |
| Tumor size(cm)(>5 vs. ≤5) | 1.19 | 0.80-1.77 | 0.39 |
| Tumor encapsulation (none vs. complete) | 0.74 | 0.49-1.10 | 0.13 |
| Tumor number (multiple vs. single) | 0.95 | 0.51-1.78 | 0.88 |
| Vascular invasion (yes vs. no) | 2.55 | 1.51-4.31 | <0.01 |
| Distant metastasis (positive vs. negative) | 0.56 | 0.21-1.47 | 0.24 |
| Differentiation (poor-moderate vs. well) | 1.74 | 1.13-2.70 | 0.01 |
| TNM stage(Ⅱ-Ⅲ-Ⅳvs.Ⅰ) | 1.62 | 1.08-2.44 | 0.02 |
| SMYD2 expression (positive vs. negative) | 2.89 | 1.87-4.46 | <0.01 |